Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer has been updated to reflect a new platform version (Revision v3.5.3 instead of v3.5.2). This is a routine site/version change that does not change the study details shown on the page.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0. This appears to be a version update without changes to the study details.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check83 days agoChange DetectedThe site banner has been updated to Revision: v3.4.2, replacing the previous government funding notice.SummaryDifference0.5%

- Check91 days agoChange DetectedA site-wide government-funding lapse notice was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.